Abstract:Abstract Background and Purpose: Chemokine-like factor (CKLF) MARVEL transmembrane domain-containing family (CMTMs), including chemokine-like factor (CKLF) and CMTM1 to CMTM8. All of these genes participate in tumor development and metastasis of hepatocellular carcinoma (HCC). However, prognosis values and the distinct roles of different CMTMs in HCC are still un-clarified.Materials and Methods: To address this issue, the study explored the function of CMTM family members in the prognosis of HCC by TCGA dataset, UALCAN, Kaplan-Meier Plotter, MethSurv, TIMER2.0 databases.Results: The CKLF and CMTM1/3/4/7/8 mRNA expression was obviously elevated in HCC tissues, while CMTM2/5/6 was lowly expressed. Besides, the mRNA level of CMTMs was closely linked to cancer stage, node metastasis status and tumor grades in HCC patients. What’s more, the expression of CMTM2/5 was correlated with favorable overall survival (OS), while high expressions CKLF and CMTM1/7 were associated with poor OS. Simultaneously, low CKLF and CMTM1/4/7 expressions were significantly relevant to better progression-free survival (PFS), while low CMTM5 expression was apparently concerned with worse PFS. In DNA methylation level, 47 CpGs of CMTMs displayed markedly prognostic values. Multivariate cox analysis also revealed that affecting shorter OS outcomes prognostic factors of CKLF and CMTM7 were independent. GSEA results suggested that CKLF and CMTM7 participated in the development and progression of HCC accompanied with multiple biological processes. Furthermore, CMTMs were dramatically associated with tumor immune infiltrating cells (TIICs) (e.g., neutrophils cells), but CMTM8 expression level was no significant correlations with TIICs.Conclusion: This study renders new insight into the prognostic values of CMTM family members in HCC. Overall, our results indicated that CKLF and CMTM7 could be the prognostic biomarkers in HCC patients.

Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.

Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer

Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).

Research advances in CKLF-like MARVEL transmembrane domain containing member 5]

Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors

AB179. CMTM3 is Reduced in Prostate Cancer and Inhibits Migration, Invasion and Growth of LNCaP Cells

Chemokine-Like Factor-Like Marvel Transmembrane Domain-Containing Family In Hepatocellular Carcinoma: Latest Advances

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 As a Novel Biomarker for Breast Cancer.

Research Advances in Chemokine-like Factor Super Family Member 8

Characterization and expression profile of CMTM3/CKLFSF3.

Cmtm3 Inhibits Cell Migration And Invasion And Correlates With Favorable Prognosis In Gastric Cancer

CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value

CMTM3 is Frequently Reduced in Clear Cell Renal Cell Carcinoma and Exhibits Tumor Suppressor Activities

CMTM3 As a Potential New Immune Checkpoint Regulator

Expression of CMTM3 and CMTM5 in clear cell renal cell carcinoma and its significance

Cmtm3, Located At The Critical Tumor Suppressor Locus 16q22.1, Is Silenced By Cpg Methylation In Carcinomas And Inhibits Tumor Cell Growth Through Inducing Apoptosis

Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

Comprehensive Analysis of the Prognosis for Chemokine-Like Factor MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma

[Knockdown of CMTM3 Promotes Migration and Invasion of PC3 Cell in Vitro].

CMTM3 Suppresses Proliferation and Osteogenic Transdifferentiation of C2C12 Myoblasts through p53 Upregulation

CMTM3 Inhibits Cell Growth and Migration and Predicts Favorable Survival in Oral Squamous Cell Carcinoma